Compare KE Holdings Inc (BEKE) vs Canopy Growth Corp (CGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KE Holdings Inc vs Canopy Growth Corp — how do they compare? KE Holdings Inc trades at $16.8 (market cap $19.20B), while Canopy Growth Corp trades at $1.02 (market cap $430.60M). The key difference: KE Holdings Inc is far larger — about 44.6× Canopy Growth Corp's market cap, and KE Holdings Inc pays a 1.58% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| BEKE | CGC | |
|---|---|---|
Market Cap | $19.20B | $430.60M |
Sector | Technology | Health |
52-Week High | $20.36 | $1.92 |
52-Week Low | $14.26 | $0.86 |
Enterprise Value | $14.94B | $388.01M |
Dividend Yield | 1.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BEKE trades at $17.42, up 2.71% today, with a bullish technical signal from moving averages and oversold conditions noted by Zacks Investment Research on 2026-06-29. Recent Q1 2026 earnings beat expectations with EPS of $0.20 versus $0.14 expected, driven by cost controls and operational efficiency. Revenue for 2025 was $94.58 billion with a net income margin of 3.76%, though cash flow from operations was negative $376.17 million.
The outlook is positive with strong analyst support (91.67% buy ratings) and potential trend reversal, but risks include volatile cash flows and China's property market exposure. Upside hinges on sustained earnings growth and market recovery, while downside risks involve macroeconomic pressures and competitive threats.
CGC trades at $1.01, up 1.0% in the last session, with a bullish technical signal from moving averages but overbought RSI readings. The company reported Q1 fiscal 2027 revenue growth of 13% year-over-year, beating estimates, yet continues to post net losses. Recent news highlights expansion in European medical cannabis markets and cost-cutting efforts, while analyst consensus is mixed with 33% buy ratings.
Outlook remains speculative with high execution risk; improving cash flow trends and potential U.S. rescheduling offer upside, but persistent negative margins and debt concerns weigh on equity value. Investors should weigh growth prospects against profitability challenges in the volatile cannabis sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KE Holdings Inc
KE Holdings (Beike) is China’s leading platform for housing transactions and services. It operates the Lianjia brand and uses data-driven technology to facilitate home sales, rentals, and home renovation services.
Read more on BEKE →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
